Drug-Resistant Hypertension


  • The purpose of this study is to observe the effects of low and high doses of the drug minocycline in patients with drug-resistant hypertension. Minocycline is an FDA-approved drug.
  • Patients diagnosed with uncontrolled hypertension who have not been able to achieve good blood pressure control after treatment with three blood pressure medications may be eligible to participate in this study.
  • Principal Investigator: Carl J. Pepine

Please contact our Clinical Trials Office for information: (352) 273-8933